Glyclopyramide
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide
|
|
Clinical data | |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 631-27-6 |
ATC code | none |
PubChem | CID: 71793 |
ChemSpider | 64820 |
UNII | KE474IKG1W |
KEGG | D01799 |
ChEMBL | CHEMBL2105083 |
Chemical data | |
Formula | C11H14ClN3O3S |
Molecular mass | 303.76 g/mol |
|
|
|
|
(what is this?) (verify) |
Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.
It is classified as second generation.[1]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- (Japanese) Deamelin-S 250 mg Tablets
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs not assigned an ATC code
- Articles with Japanese-language external links
- Sulfonylureas
- Pyrrolidines
- Chloroarenes
- Gastrointestinal system drug stubs